Janas-Naze Anna, Zhang Wei, Szuta Mariusz
Department of Oral Surgery, Medical University of Lodz, 92-213 Lodz, Poland.
Shanxi Oral Disease Prevention and Treatment Center, Shanxi Provincial People's Hospital, Taiyuan 030012, China.
J Clin Med. 2023 Feb 1;12(3):1133. doi: 10.3390/jcm12031133.
To date, few studies have been conducted to test the effectiveness of Carnoy's (CS) versus modified Carnoy's (MC) solution for preventing the recurrence of odontogenic keratocysts, which are potentially aggressive lesions. To evaluate the efficacy of MC application, we conducted a retrospective cohort study over an 18-year period, from October 2004 to October 2022, in 122 patients treated surgically with adjunctive chemical cautery, with either CS (n = 73; median age: 30 years) or MC (n = 49; median age: 42 years), by a single surgeon. The primary outcome variables were observed recurrence and interval to recurrence. Independent variables were demographics, location, clinical presentation at baseline, adjacent tooth extraction, and bone grafting. Males predominated in both groups. No statistically significant differences were observed between the two arms in terms of recurrences in particular months, with six patients (8.2%) in the CS arm and 5 (10.2%) in the MC arm. Of the 11 recurrences, 10 were observed within the first 2 years post-surgery, with only one occurring in the 7th year of follow-up. Thus, when used as adjunctive therapy, the application of MC has an efficiency comparable to that of CS for lowering the recurrence rate of odontogenic keratocysts.
迄今为止,很少有研究对卡诺氏液(CS)与改良卡诺氏液(MC)预防牙源性角化囊肿复发的有效性进行测试,牙源性角化囊肿是具有潜在侵袭性的病变。为了评估应用MC的疗效,我们进行了一项回顾性队列研究,研究时间跨度为18年,从2004年10月至2022年10月,纳入了122例接受手术辅助化学烧灼治疗的患者,这些患者由同一位外科医生采用CS(n = 73;中位年龄:30岁)或MC(n = 49;中位年龄:42岁)进行治疗。主要结局变量为观察到的复发情况和复发间隔。自变量包括人口统计学特征、病变位置、基线临床表现、邻牙拔除情况和植骨情况。两组均以男性为主。两组在特定月份的复发率方面未观察到统计学上的显著差异,CS组有6例患者(8.2%)复发,MC组有5例患者(10.2%)复发。在11例复发病例中,10例在术后头2年内观察到,仅1例在随访第7年出现。因此,当用作辅助治疗时,应用MC降低牙源性角化囊肿复发率的效率与CS相当。